US 9717759
Modification of CXCR4 using engineered zinc finger proteins
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 9717759 (Modification of CXCR4 using engineered zinc finger proteins) held by Sangamo Therapeutics, Inc. expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K40/11, A61K40/46